David Beck, MD, PhD received his MD/PhD at New York University School of Medicine and further clinical training at Columbia University in Internal Medicine and the National Institutes of Health in clinical genetics. David performed his postdoctoral research with Dr. Dan Kastner at the National Human Genome Research Institute studying the genetics and mechanism underlying a subset of rheumatic diseases called autoinflammatory syndromes. David's work focused on discovering and characterizing new genetic diseases, including VEXAS syndrome which he will talk about today. David joined the faculty at New York University School of Medicine last year to run a translational program studying autoinflammatory diseases, including VEXAS syndrome, both in the clinic and in the laboratory. His lab focuses on trying to identify genetic causes of diseases in patients, and use laboratory investigation to help provide insights for clinical care.
Stay informed and at the forefront of groundbreaking discoveries by subscribing to our newsletter, your essential source for the latest research updates from the Colton Center for Autoimmunity Consortium.